Journal
CIRCULATION
Volume 138, Issue 2, Pages 150-153Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.118.035107
Keywords
Editorials; C-reactive protein; inflammation; lipoproteins; LDL; myocardial infarction; risk factors
Funding
- Novartis
- Pfizer
- DalCor
- Sanofi
- Kowa
- Amgen
- AstraZeneca